The myeloproliferative blood cancers—essential thrombocytosis (ET

$ 26.50

4.6 (532) In stock

VA Benefits for Essential Thrombocythemia and Primary Myelofibrosis

Myeloproliferative blood cancers as a human neuroinflammation

Christina ELLERVIK, MD, PhD

Myeloproliferative Neoplasms Leukemia and Lymphoma Society

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

Christina ELLERVIK, MD, PhD

Troels WIENECKE Chief Physician, clinical associate professor

Essential thrombocythemia (ET) – MPN Research Foundation

Chronic Myeloproliferative Neoplasms Treatment - NCI

Lasse Kjær's research works Zealand University Hospital, Køge

Essential thrombocythemia (ET) – MPN Research Foundation